VEGFA and gastric cancer: MiR-574-5p targets tyrosine–protein phosphatase non-receptor type 3 (PTPN3) to enhance phosphorylation of ERK and VEGF-A expression, thereby promoting angiogenesis in gastric cancer (Zhang, 2020a, b, c, d).